Merck KGaA also considers direct-to-patient US sales Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T W Thu F 7 August, 2025

Stay on the cutting edge of healthcare innovations with access to the latest insights. sponsored by HSBC

spotlight Live at 12 p.m. ET: What we learned from Q2 earnings about China, tariffs and Trump

news Lilly's rise in revenue clouded by Phase 3 obesity pill readout •  Lilly’s obesity pill is less effective than Novo’s, pivotal data suggest FDA removes hold on Valneva’s chikungunya vaccine in those over 60, adjusts product label Merck KGaA joins other drugmakers in considering direct-to-patient US sales  Iovance trims workforce after cell therapy sales missed expectations Elevidys sales fall again in Sarepta's second quarter amid safety issues Sixth Circuit judges uphold decision over IRA drug price negotiations in government’s favor

Principal - Life Science Alexandria Real Estate Equities San Francisco, CA, USA Senior Director of IT Caribou Biosciences, Inc. Berkeley, CA, USA Director Of Business Development, Health And Biomedical Innovation Brown University Providence, RI, USA Senior Patent Counsel Caribou Biosciences, Inc. Berkeley, CA, USA Head of Lab Operations Terray Therapeutics, Inc. Monrovia, CA, USA Principal Scientist, Molecular Design Terray Therapeutics, Inc. Monrovia, CA, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

Aug 21 2:00pm ET Agentic AI is here: Real-world applications in life sciences & healthcare sponsored by IBM

Big Pharma is doubling down. Startups are going all in. Who’s actually making AI work in drug R&D? Join the debate — online in the morning for everyone and in person for live-only content and a reception in the evening at NYC’s Georgia Room. Choose your pass today.

endpoints pharma OpenAI-backed biotech Chai Discovery raises $70M Series A Novavax expects post-marketing Covid study to cost up to $90M Novo Nordisk, Sanofi, Lilly to face renewed fight over alleged 340B price fixing FDA approves targeted brain cancer drug from Jazz’s Chimerix buyout

in case you missed it 1. As competition heats up, BridgeBio's Attruby sales underwhelm Wall Street despite growth 2.